Suppr超能文献

p53的四聚化缺陷会导致异常的泛素化和转录活性。

Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity.

作者信息

Lang Valérie, Pallara Chiara, Zabala Amaia, Lobato-Gil Sofia, Lopitz-Otsoa Fernando, Farrás Rosa, Hjerpe Roland, Torres-Ramos Monica, Zabaleta Lorea, Blattner Christine, Hay Ronald T, Barrio Rosa, Carracedo Arkaitz, Fernandez-Recio Juan, Rodríguez Manuel S, Aillet Fabienne

机构信息

Ubiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, Mikeletegi 81, San Sebastián-Donostia 20009, Gipuzkoa, Spain.

Joint BSC-IRB Research Program in Computational Biology, Life Sciences Department, Barcelona Supercomputing Center, Carrer Jordi Girona 29, 08034 Barcelona, Spain.

出版信息

Mol Oncol. 2014 Jul;8(5):1026-42. doi: 10.1016/j.molonc.2014.04.002. Epub 2014 Apr 13.

Abstract

The tumor suppressor p53 regulates the expression of genes involved in cell cycle progression, senescence and apoptosis. Here, we investigated the effect of single point mutations in the oligomerization domain (OD) on tetramerization, transcription, ubiquitylation and stability of p53. As predicted by docking and molecular dynamics simulations, p53 OD mutants show functional defects on transcription, Mdm2-dependent ubiquitylation and 26S proteasome-mediated degradation. However, mutants unable to form tetramers are well degraded by the 20S proteasome. Unexpectedly, despite the lower structural stability compared to WT p53, p53 OD mutants form heterotetramers with WT p53 when expressed transiently or stably in cells wild type or null for p53. In consequence, p53 OD mutants interfere with the capacity of WT p53 tetramers to be properly ubiquitylated and result in changes of p53-dependent protein expression patterns, including the pro-apoptotic proteins Bax and PUMA under basal and adriamycin-induced conditions. Importantly, the patient derived p53 OD mutant L330R (OD1) showed the more severe changes in p53-dependent gene expression. Thus, in addition to the well-known effects on p53 stability, ubiquitylation defects promote changes in p53-dependent gene expression with implications on some of its functions.

摘要

肿瘤抑制因子p53可调节参与细胞周期进程、衰老和凋亡的基因表达。在此,我们研究了寡聚化结构域(OD)中的单点突变对p53四聚化、转录、泛素化和稳定性的影响。正如对接和分子动力学模拟所预测的,p53 OD突变体在转录、Mdm2依赖的泛素化和26S蛋白酶体介导的降解方面表现出功能缺陷。然而,无法形成四聚体的突变体可被20S蛋白酶体有效降解。出乎意料的是,尽管与野生型p53相比结构稳定性较低,但p53 OD突变体在野生型或p53缺失的细胞中瞬时或稳定表达时,可与野生型p53形成异源四聚体。因此,p53 OD突变体干扰了野生型p53四聚体被正确泛素化的能力,并导致p53依赖的蛋白质表达模式发生变化,包括在基础和阿霉素诱导条件下的促凋亡蛋白Bax和PUMA。重要的是,患者来源的p53 OD突变体L330R(OD1)在p53依赖的基因表达中表现出更严重的变化。因此,除了对p53稳定性的众所周知的影响外,泛素化缺陷还会促进p53依赖的基因表达变化,从而影响其某些功能。

相似文献

1
Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity.
Mol Oncol. 2014 Jul;8(5):1026-42. doi: 10.1016/j.molonc.2014.04.002. Epub 2014 Apr 13.
2
Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Int J Biochem Cell Biol. 2010 May;42(5):725-35. doi: 10.1016/j.biocel.2010.01.010. Epub 2010 Jan 18.
3
Mdm2 facilitates the association of p53 with the proteasome.
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10038-43. doi: 10.1073/pnas.0911716107. Epub 2010 May 17.
4
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers.
Genes Dev. 2018 Mar 1;32(5-6):430-447. doi: 10.1101/gad.304071.117. Epub 2018 Mar 16.
5
Negative regulation of p53 by Ras superfamily protein RBEL1A.
J Cell Sci. 2013 Jun 1;126(Pt 11):2436-45. doi: 10.1242/jcs.118117. Epub 2013 Apr 9.
6
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Mol Cell Biol. 2000 Nov;20(22):8458-67. doi: 10.1128/MCB.20.22.8458-8467.2000.
7
Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
J Biol Chem. 2010 Jul 23;285(30):22818-30. doi: 10.1074/jbc.M110.126920. Epub 2010 May 18.
8
Abnormal MDMX degradation in tumor cells due to ARF deficiency.
Oncogene. 2012 Aug 9;31(32):3721-32. doi: 10.1038/onc.2011.534. Epub 2011 Nov 28.
9
Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
J Biol Chem. 1999 Jun 4;274(23):16531-5. doi: 10.1074/jbc.274.23.16531.
10
XPC promotes MDM2-mediated degradation of the p53 tumor suppressor.
Mol Biol Cell. 2014 Jan;25(2):213-21. doi: 10.1091/mbc.E13-05-0293. Epub 2013 Nov 20.

引用本文的文献

1
Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant.
PLoS One. 2025 May 7;20(5):e0322096. doi: 10.1371/journal.pone.0322096. eCollection 2025.
2
p53: The Multifaceted Roles of Covalent Modifications in Cancer.
Pharmaceuticals (Basel). 2024 Dec 13;17(12):1682. doi: 10.3390/ph17121682.
4
Germline variant affecting p53β isoforms predisposes to familial cancer.
Nat Commun. 2024 Sep 18;15(1):8208. doi: 10.1038/s41467-024-52551-8.
5
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.
Clin Cancer Res. 2024 Oct 15;30(20):4701-4713. doi: 10.1158/1078-0432.CCR-24-1835.
6
Association of germline variants with somatic variants in breast tumors in a genome-wide study.
medRxiv. 2023 Dec 6:2023.12.06.23299442. doi: 10.1101/2023.12.06.23299442.
7
p53 and Its Isoforms in Renal Cell Carcinoma-Do They Matter?
Biomedicines. 2022 Jun 6;10(6):1330. doi: 10.3390/biomedicines10061330.
8
p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies.
Cancers (Basel). 2021 Jun 9;13(12):2885. doi: 10.3390/cancers13122885.
9
p53 tetramerization: at the center of the dominant-negative effect of mutant p53.
Genes Dev. 2020 Sep 1;34(17-18):1128-1146. doi: 10.1101/gad.340976.120.

本文引用的文献

1
Gene expression: degrade to derepress.
EMBO J. 2014 Mar 3;33(5):407-8. doi: 10.1002/embj.201387752. Epub 2014 Jan 28.
3
Revised AMBER parameters for bioorganic phosphates.
J Chem Theory Comput. 2012 Nov 13;8(11):4405-4412. doi: 10.1021/ct300613v. Epub 2012 Sep 12.
4
miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
PLoS One. 2012;7(11):e50469. doi: 10.1371/journal.pone.0050469. Epub 2012 Nov 29.
5
Isolation of ubiquitylated proteins using tandem ubiquitin-binding entities.
Methods Mol Biol. 2012;832:173-83. doi: 10.1007/978-1-61779-474-2_12.
6
MoDEL (Molecular Dynamics Extended Library): a database of atomistic molecular dynamics trajectories.
Structure. 2010 Nov 10;18(11):1399-409. doi: 10.1016/j.str.2010.07.013.
7
Overview of macroautophagy regulation in mammalian cells.
Cell Res. 2010 Jul;20(7):748-62. doi: 10.1038/cr.2010.82. Epub 2010 Jun 15.
8
Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Int J Biochem Cell Biol. 2010 May;42(5):725-35. doi: 10.1016/j.biocel.2010.01.010. Epub 2010 Jan 18.
9
Tumor suppressive functions of p53.
Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a001883. doi: 10.1101/cshperspect.a001883.
10
Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities.
EMBO Rep. 2009 Nov;10(11):1250-8. doi: 10.1038/embor.2009.192. Epub 2009 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验